| Christopher C Tuveson, MD | |
|
420 E Division St, Fond Du Lac, WI 54935-4560 | |
| (920) 926-8495 | |
| Not Available |
| Full Name | Christopher C Tuveson |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 32 Years |
| Location | 420 E Division St, Fond Du Lac, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023091386 | NPI | - | NPPES |
| 32427700 | Medicaid | WI | |
| 340014901 | Other | WI | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 39750 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Agnes Hospital | Fond du lac, WI | Hospital |
| Waupun Memorial Hospital | Waupun, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Agnesian Healthcare Inc | 1658289624 | 319 |
News Archive
BG Medicine, Inc. today announced that it has entered into a research collaboration with Merck, through a subsidiary, for the development and validation of a novel biomarker with potential application in the management of lipid disorders. BG Medicine will pursue development and validation of an immunoassay and investigate its clinical utility as a biomarker. If successful, BG Medicine plans to complete the development and validation studies and seek regulatory clearance for the test.
The Automation Partnership, a leading supplier of innovative automation for life science applications today announced that the company will now be known as TAP Biosystems.
Delphi Display Systems, Inc., today announced that it has been selected to provide a turnkey digital signage solution for MedMedia Healthcare Network to be installed in the waiting rooms of doctors' offices and medical clinics located in Southern California.
Researchers in the United States have warned that as of July 15th this year (2021), the level of population immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – may still have been insufficient to contain infection outbreaks and safely return to pre-pandemic social behavior.
South Korea-based Medyssey Co., Ltd. announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Administration for its Zenius Thoracolumbar Spinal System. Though currently available in limited release, Medyssey will launch the new Zenius System in the United States in Q4.
› Verified 6 days ago
| Entity Name | Agnesian Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346228541 PECOS PAC ID: 1658289624 Enrollment ID: O20031104000263 |
News Archive
BG Medicine, Inc. today announced that it has entered into a research collaboration with Merck, through a subsidiary, for the development and validation of a novel biomarker with potential application in the management of lipid disorders. BG Medicine will pursue development and validation of an immunoassay and investigate its clinical utility as a biomarker. If successful, BG Medicine plans to complete the development and validation studies and seek regulatory clearance for the test.
The Automation Partnership, a leading supplier of innovative automation for life science applications today announced that the company will now be known as TAP Biosystems.
Delphi Display Systems, Inc., today announced that it has been selected to provide a turnkey digital signage solution for MedMedia Healthcare Network to be installed in the waiting rooms of doctors' offices and medical clinics located in Southern California.
Researchers in the United States have warned that as of July 15th this year (2021), the level of population immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – may still have been insufficient to contain infection outbreaks and safely return to pre-pandemic social behavior.
South Korea-based Medyssey Co., Ltd. announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Administration for its Zenius Thoracolumbar Spinal System. Though currently available in limited release, Medyssey will launch the new Zenius System in the United States in Q4.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher C Tuveson, MD 420 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 926-8340 | Christopher C Tuveson, MD 420 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 926-8495 |
News Archive
BG Medicine, Inc. today announced that it has entered into a research collaboration with Merck, through a subsidiary, for the development and validation of a novel biomarker with potential application in the management of lipid disorders. BG Medicine will pursue development and validation of an immunoassay and investigate its clinical utility as a biomarker. If successful, BG Medicine plans to complete the development and validation studies and seek regulatory clearance for the test.
The Automation Partnership, a leading supplier of innovative automation for life science applications today announced that the company will now be known as TAP Biosystems.
Delphi Display Systems, Inc., today announced that it has been selected to provide a turnkey digital signage solution for MedMedia Healthcare Network to be installed in the waiting rooms of doctors' offices and medical clinics located in Southern California.
Researchers in the United States have warned that as of July 15th this year (2021), the level of population immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – may still have been insufficient to contain infection outbreaks and safely return to pre-pandemic social behavior.
South Korea-based Medyssey Co., Ltd. announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Administration for its Zenius Thoracolumbar Spinal System. Though currently available in limited release, Medyssey will launch the new Zenius System in the United States in Q4.
› Verified 6 days ago
Sean P Hedican, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 420 E Division St, Fond Du Lac, WI 54935 Phone: 209-268-4959 Fax: 920-926-8386 | |
James E Cauley, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 420 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-8495 Fax: 920-926-8386 | |
Aaron R Johnson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 420 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-8495 | |
James A Wright, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 420 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-8495 |